Hasil Pencarian - D. H. Yoon

  • Menampilkan 1 - 8 hasil dari 8
Perbaiki Hasil
  1. 1
    Proteome Analysis of Bovine Muscle Associated with the Marbling Score

    Proteome Analysis of Bovine Muscle Associated with the Marbling Score oleh Y. N. Shen, S. H. Kim, D. H. Yoon, H. G. Lee, H. S. Kang, K. S. Seo

    Diterbitkan 2012-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Determination of Genetic Diversity among Korean Hanwoo Cattle Based on Physical Characteristics

    Determination of Genetic Diversity among Korean Hanwoo Cattle Based on Physical Characteristics oleh T. J. Choi, S. S. Lee, D. H. Yoon, H. S. Kang, C. D. Kim, I. H. Hwang, C. Y. Kim, X. Jin, C. G. Yang, K. S. Seo

    Diterbitkan 2012-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    P1123: TEMPO: A PHASE 2, RANDOMIZED, OPEN-LABEL, 2-ARM STUDY COMPARING TWO INTERMITTENT DOSING SCHEDULES OF DUVELISIB IN SUBJECTS WITH INDOLENT NON-HODGKIN LYMPHOMA (INHL)

    P1123: TEMPO: A PHASE 2, RANDOMIZED, OPEN-LABEL, 2-ARM STUDY COMPARING TWO INTERMITTENT DOSING SCHEDULES OF DUVELISIB IN SUBJECTS WITH INDOLENT NON-HODGKIN LYMPHOMA (INHL) oleh V. Vorobyev, D. H. Yoon, M. Kaźmierczak, S. Grosicki, C. Tarella, A. Genua, J. S. Kim, D. Cohan, M. Daugherty, I. W. Flinn, P. L. Zinzani, L. I. Gordon

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    PB2133: ASSESSING SAFETY, TOLERABILITY, AND EFFICACY OF SUBCUTANEOUS EPCORITAMAB IN NOVEL COMBINATIONS WITH ANTI-NEOPLASTIC AGENTS IN PATIENTS WITH NON-HODGKIN LYMPHOMA IN A PHASE 1B/2, OPEN-LABEL STUDY

    PB2133: ASSESSING SAFETY, TOLERABILITY, AND EFFICACY OF SUBCUTANEOUS EPCORITAMAB IN NOVEL COMBINATIONS WITH ANTI-NEOPLASTIC AGENTS IN PATIENTS WITH NON-HODGKIN LYMPHOMA IN A PHASE... oleh L. H. Sehn, I. Avivi, J. Brody, D. H. Yoon, B. M. Elliott, S. R. Siddani, Y. Bai, A. Parikh, M. M. Seliem, M. H. Dinh, A. P. Skarbnik

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    PB2111: SUBGROUP ANALYSIS IN RE-MIND2, AN OBSERVATIONAL, RETROSPECTIVE COHORT STUDY OF TAFASITAMAB + LENALIDOMIDE VERSUS SYSTEMIC THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

    PB2111: SUBGROUP ANALYSIS IN RE-MIND2, AN OBSERVATIONAL, RETROSPECTIVE COHORT STUDY OF TAFASITAMAB + LENALIDOMIDE VERSUS SYSTEMIC THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY DIF... oleh G. S. Nowakowski, D. H. Yoon, E. Joffe, P. L. Zinzani, L. Sabatelli, E. E. Waltl, C. G. Alvero, G. Hess, P. Riedell, K. Kim, D. Brixner, G. Salles

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Genetic Polymorphisms of the Bovine NOV Gene Are Significantly Associated with Carcass Traits in Korean Cattle

    Genetic Polymorphisms of the Bovine NOV Gene Are Significantly Associated with Carcass Traits in Korean Cattle oleh B. S. Kim, S. C. Kim, C. M. Park, S. H. Lee, S. H. Cho, N. K. Kim, G. W. Jang, D. H. Yoon, B. S. Yang, S. K. Hong, H. H. Seong, B. H. Choi

    Diterbitkan 2013-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    PB2035: CAMMA 3: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF SUBCUTANEOUS CEVOSTAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

    PB2035: CAMMA 3: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF SUBCUTANEOUS CEVOSTAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY M... oleh S. Delimpasi, H. Quach, M. Cavo, P. J. Ho, C. H.-S. Lee, A. Santoro, R. Schots, P. Vlummens, D. H. Yoon, S.-S. Yoon, C. D. Santos, D. Samineni, J. Huang, K. Wehrman, U. Patil, S. Sheikh, M. A. Dimopoulos

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    S218: A PHASE I/II STUDY OF GOLIDOCITINIB, A SELECTIVE JAK1 INHIBITOR, IN REFRACTORY OR RELAPSED PERIPHERAL T CELL LYMPHOMA

    S218: A PHASE I/II STUDY OF GOLIDOCITINIB, A SELECTIVE JAK1 INHIBITOR, IN REFRACTORY OR RELAPSED PERIPHERAL T CELL LYMPHOMA oleh W.-S. Kim, D.-H. Yoon, Y. Song, H. Yang, J. Cao, D. Ji, Y. Koh, H. Jing, H.-S. Eom, J.-Y. Kwak, W.-S. Lee, J.-S. Lee, H.-J. Shin, J. Jin, M. Wang, J. Li, X. Huang, X. Deng, Z. Yang, J. Zhu

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: